After registering a 52-week high, the stock is consistently falling along with relatively low volume and making a series of lower lows. Currently, the stock has reached near its multiple support zone of Rs. 200-Rs. 190 and it is likely to give a bounce from the current levels in the coming weeks. 

The stocks most likely to witness significant movement on the bourses on December 12 are Unichem Laboratories, Shalby, Palred Technologies, SBI and Music Broadcast.

The Indian benchmark indices closed with gains despite experiencing volatile trade on Tuesday. Yes Bank was the top gainers on both the benchmarks Sensex and Nifty. Broader markets also participated in the rally with Mid-cap and Small-cap indices gaining more than 1 per cent.

Following stocks are close to their 52-week low as at 02.03 p.m. on Dec 11, 2018.

The markets on Dec 11, 2018 opened gap up. BSE Sensex is trading at 35,060.86 up by 101.14 points and the Nifty is trading at 10,521 up by 28.20 points. 

The pharma major launched omeprazole delayed-release tablets, 20 mg, an over-the-counter (OTC) equivalent of Prilosec OTC in the US market. This has helped the stock trade in the green in an otherwise volatile market on Tuesday.

Overall volumes in futures & options currently stand at 78, 93,174 contracts with a turnover of Rs. 4, 79,808.70 crore.

Overall volumes in futures & options currently stand at 78, 93,174 contracts with a turnover of Rs. 4, 79,808.70 crore.

Strides Pharma Science Limited's 50:50 JV Strides Vivimed has got USFDA approval for Albendazole Tablets on Tuesday. The US market for the said tablets is around US$100mn as per IQVIA MAT data.